NorthCrest Asset Manangement’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
53,103
+7,712
| +17% | +$196K | 0.04% | 267 |
|
|
2025
Q1 | $1.15M | Buy |
45,391
+6,440
| +17% | +$163K | 0.03% | 280 |
|
|
2024
Q4 | $1.03M | Sell |
38,951
-17,115
| -31% | -$454K | 0.03% | 290 |
|
|
2024
Q3 | $1.62M | Sell |
56,066
-2,787
| -5% | -$80.7K | 0.05% | 224 |
|
|
2024
Q2 | $1.65M | Sell |
58,853
-556
| -0.9% | -$15.6K | 0.05% | 217 |
|
|
2024
Q1 | $1.65M | Buy |
59,409
+6,221
| +12% | +$173K | 0.06% | 218 |
|
|
2023
Q4 | $1.53M | Sell |
53,188
-443,915
| -89% | -$12.8M | 0.06% | 216 |
|
|
2023
Q3 | $16.5M | Sell |
497,103
-23,526
| -5% | -$780K | 0.67% | 42 |
|
|
2023
Q2 | $19.1M | Buy |
520,629
+7,913
| +2% | +$290K | 0.76% | 34 |
|
|
2023
Q1 | $20.9M | Buy |
512,716
+493,170
| +2,523% | +$20.1M | 0.87% | 28 |
|
|
2022
Q4 | $1M | Sell |
19,546
-408,841
| -95% | -$21M | 0.06% | 189 |
|
|
2022
Q3 | $18.7M | Buy |
428,387
+18,170
| +4% | +$795K | 1.01% | 17 |
|
|
2022
Q2 | $21.5M | Buy |
410,217
+5,451
| +1% | +$286K | 1.1% | 12 |
|
|
2022
Q1 | $21M | Buy |
404,766
+391,194
| +2,882% | +$20.3M | 0.99% | 23 |
|
|
2021
Q4 | $801K | Buy |
+13,572
| New | +$801K | 0.04% | 253 |
|